The Advanced Immunology and Microbial Sciences division is a connection point for multidisciplinary scientists at TGen with a combined mission of positively impacting human health through the understanding of the interaction between humans and disease agents. We use advanced genomics and immunological tools to better understand pathogens, cancers, and the environment to improve the health of patients and populations.
A team of researchers co-led by TGen, part of City of Hope, have uncovered important molecular signatures that could help predict the progression of hepatic steatosis, a liver condition linked to obesity and other metabolic disorders.
Read ArticleTGen announced the appointment of John Fryer, Ph.D., as a professor in the Division of Bioinnovation and Genome Sciences and director of the newly established Center for Accelerated Nanotherapeutics. The appointment further advances TGen’s mission to accelerate leading-edge research in the fight against Alzheimer’s and other devastating diseases.
Read ArticleGlyphosate exposure linked to Alzheimer’s disease-like pathology in pre-clinical models
Read ArticleNicholas Banovich, Ph.D., associate professor and division director of Bioinnovation and Genome Sciences at TGen, part of City of Hope, will lead or co-lead three collaborative grants totaling over $22 million, with $8.2 million supporting research at TGen.
Read ArticlePHOENIX, Ariz. — Oct. 29, 2024 — TGen, part of City of Hope, and its partners in the Longevity Consortium have received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.
Read ArticleTGen’s Pathogen and Microbiome Division (TGen North) advances work with the human microbiome. The scientists at TGen North explain how the world of these tiny microbes affects our health and how our health affects our microbiome. At TGen, our team of microbial explorers make the future of health science happen today.